These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy. Maár N, Ergun E, Luksch A, Stur M. Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450 [Abstract] [Full Text] [Related]
24. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Pece A, Isola V, Vadalà M, Calori G. Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590 [Abstract] [Full Text] [Related]
26. Retinal function following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration: a short-term study by focal electroretinography. Pirozzi E, Manganelli C, Piccardi M, Minnella A, Fadda A, Ziccardi L, Coccimiglio F, Falsini B. Acta Ophthalmol Scand; 2006 Feb; 84(1):27-35. PubMed ID: 16445436 [Abstract] [Full Text] [Related]
30. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series. Lam DS, Liu DT, Fan DS, Lai WW, So SF, Chan WM. Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364 [Abstract] [Full Text] [Related]
33. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM, United Kingdom PDT Users Group. Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757 [Abstract] [Full Text] [Related]
34. Effects of verteporfin therapy on central visual field function. Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Ophthalmology; 2004 May; 111(5):931-9. PubMed ID: 15121371 [Abstract] [Full Text] [Related]
35. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M. Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524 [Abstract] [Full Text] [Related]
36. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Potter MJ, Szabo SM, Ho T. Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):639-41. PubMed ID: 16175378 [Abstract] [Full Text] [Related]
37. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC, Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216 [Abstract] [Full Text] [Related]
38. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia. Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, D'Angelo S, Perri P, Sebastiani A, Incorvaia C. Ophthalmology; 2010 Mar; 117(3):517-23. PubMed ID: 20044141 [Abstract] [Full Text] [Related]
39. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients]. Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL. Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900 [Abstract] [Full Text] [Related]
40. Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia. Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Hayashi W, Wang J, Yoshida T, Tokoro T, Mochizuki M. Am J Ophthalmol; 2011 Jan; 151(1):137-147.e1. PubMed ID: 20970774 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]